Last edition
News about "Christine Roth"
US FDA Approves Finerenone for CKD in Type 1 Diabetes
The US FDA has approved finerenone for a new indication: treating Chronic Kidney Disease associated with Type 1 Diabetes in patients.
Christine Roth | 21/09/2026 | By News Bureau | 105
Japan Approves Bayer's Sevabertinib for HER2-Mutant NSCLC
Japan approves Bayer’s sevabertinib as the first targeted therapy for HER2-mutant NSCLC, including first-line use, based on phase 1/2 SOHO-01 results.
Christine Roth | 25/08/2026 | By News Bureau | 122
Bayer Secures Japanese Approval for Finerenone
Bayer has received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for Finerenone (Kerendia), a non-steroidal, selective mineralocorticoid receptor antagonist, for the treatment of adult patients with chronic heart failure with mildly reduced or preserved Left Ventricular Ejection Fraction (LVEF).
Christine Roth | 23/12/2025 | By News Bureau | 600
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy